©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
Table 2 Clinical outcomes of heart transplant recipients at 1-year and 3-year post-transplant
| At transplant | 1-year post transplant (n = 260) | 3-year post-transplant (n = 230) | |
| Survival | N/A | 93% | 85% |
| Weight (kg) | 86 ± 18 | 88 ± 19 | 91 ± 20a |
| Body mass index | 28 ± 5 | 28 ± 5 | 29 ± 6a |
| > 30 kg/m2 | 35% | 36% | 40% |
| Left ventricular ejection fraction (%) | N/A | 59 ± 5 | 60 ± 6 |
| < 50% | N/A | 2% | 2% |
| Presence of donor specific antibodies | N/A | 23% | 26% |
| Coronary artery vasculopathy | |||
| Grade 0 | N/A | 80% | 75% |
| Grade 1 | N/A | 16% | 18% |
| Grade 2-3 | N/A | 0% | 4% |
- Citation: Rajagopalan N, Dennis DR, Akhtarekhavari J, Campbell K. Abnormal invasive hemodynamics in heart transplant recipients: A single-center, retrospective study. World J Transplant 2025; 15(3): 101245
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/101245.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.101245